Diabetes Technology Policies: A Retrospective Descriptive Analysis of Policy Quality and Update Based on Current Best-Practices
MetadataShow full item record
Background and Significance There is often confusion surrounding diabetes technology in the perioperative area, leading to dissatisfaction, lapses in patient safety, and increased cost. Purpose, Aims and Objectives The purpose of this project was to develop criteria evaluating existing diabetes technology policies, determine their adequacy, then develop a policy guideline, based on current best practices, for dissemination to facilities with perioperative settings. Theoretical Framework The integrated Promoting Action on Research Implementation in Health Services (i-PARiHS) framework was applied. Methods and Design The project design was a retrospective, descriptive analysis of policy quality using a quantitative tool. Samples were diabetes technology policies from surgical facilities within the United States. Results 16 policies were reviewed. Majority were from academic medical centers (53%), created within the last ten years (56%), and updated within the last two years (82%). 76% had a diabetes specialist involved in its creation and those that did not had a lower average score. Only two policies fully met the criteria, while half of the policies somewhat met the criteria, indicating a fair policy. Conclusion Overall low scores indicate the need for policy guidance and improvement, even among top scorers. Policies from large, academic facilities, and those with the involvement of diabetes specialists yielded higher scores. Future Implications and Recommendations Diabetes technology is an evolving field with many opportunities for future research, specifically, the use of diabetes devices in the presence of diathermic surgical instruments, as well as automated insulin delivery systems in the perioperative area.